Improving intravenous fluid prescribing.

#ivfluidscot intravenous fluids patient safety prescribing quality improvement

Journal

The journal of the Royal College of Physicians of Edinburgh
ISSN: 2042-8189
Titre abrégé: J R Coll Physicians Edinb
Pays: England
ID NLM: 101144324

Informations de publication

Date de publication:
Jun 2020
Historique:
entrez: 23 6 2020
pubmed: 23 6 2020
medline: 29 7 2021
Statut: ppublish

Résumé

Intravenous (IV) fluid therapy is integral to the care of patients in hospitals but involves complex decisions. Errors in fluid prescribing are common, leading to significant harm due to inappropriate fluid type, rate or volume. British national guidelines have been developed to improve prescribing, but adherence has been generally poor. The Scottish Government has set up a National IV Fluid Improvement Programme to implement national guidelines throughout Scotland. This article reviews the need for such guidance and discusses how the Scottish National IV Fluid Improvement Programme hopes to achieve its aims across Scotland. This may provide an improvement framework for fluid prescribing in other regions.

Identifiants

pubmed: 32568296
doi: 10.4997/JRCPE.2020.224
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

181-187

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Déclaration de conflit d'intérêts

Dr Clark reports grants from Scottish Government to NHS Grampian for the National Intravenous Fluid Programme. Dr Johnston reports grants from Scottish Government to NHS Grampian for the National Intravenous Fluid Programme.

Auteurs

Abhinav Mathur (A)

University of Aberdeen, Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, Aberdeen, UK, Email: abhinav.mathur@nhs.net.

Gwen Johnston (G)

Aberdeen Anaesthestic Department, Aberdeen Royal Infirmary, Aberdeen, UK.

Laura Clark (L)

Renal Unit, Aberdeen Royal Infirmary, Aberdeen, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH